All potential acute ischemic stroke patients meeting criteria for the use of IV tPA should be offered treatment. The facts are clear, and all that remains is further provider and patient education.

Use of recombinant tissue plasminogen activator (alteplase) for treatment of acute ischemic stroke outside the criteria of guidelines and licenses is not uncommon. Most important situations of off ...